Introduction

Product design and development represents a foundational discipline within food manufacturing that encompasses the systematic process of creating new food products or modifying existing products to meet consumer needs, market requirements, and regulatory obligations. The practice extends beyond simple recipe formulation; it constitutes a comprehensive, multi-stage process through which conceptual ideas are transformed into market-ready products that satisfy stringent safety, quality, and legal standards.

In the context of food manufacturing, product design and development encompasses several interconnected activities: formulation development, process specification, hazard identification and control, packaging evaluation, shelf-life determination, and the eventual transition from laboratory and pilot-scale production to full commercial manufacturing. The discipline demands expertise spanning food science, microbiology, engineering, regulatory compliance, and operational management. A formal, documented procedure governing this activity is essential not merely as a compliance matter, but as a practical necessity to ensure that products manufactured are consistently safe, lawful, and of the intended quality.

The scope of product design and development procedures should address not only entirely new product introductions but also material changes to existing products—whether those changes affect product formulation, packaging systems, manufacturing processes, or the processes used by external parties on behalf of the manufacturer. This inclusive approach recognises that changes to established products can introduce previously unconsidered hazards or alter the control mechanisms upon which safety depends.

Significance and Intent

The primary intent of establishing comprehensive product design and development procedures is to embed food safety thinking at the point of earliest conception rather than attempting to retrofit safety controls at later stages. This preventive philosophy significantly reduces the risk that new or modified products will introduce unacceptable hazards to consumers or compromise the safety of the manufacturing environment itself.

From a food safety perspective, the significance of rigorous product design and development procedures rests upon several critical foundations. First, the formulation and composition of a product—including the selection, proportions, and origin of raw materials—directly determine what hazards may be present in the final product and whether existing control measures remain effective. A seemingly minor change to a raw material source, for instance, might introduce a new allergen, microbiological pathogen, or chemical contaminant previously absent from the supply chain. Second, the manufacturing process specified for a product determines the adequacy of existing controls and may necessitate modification to existing production arrangements, equipment settings, or environmental conditions. Third, the intended use of a product and the consumer groups anticipated to consume it—particularly whether vulnerable populations such as infants, elderly persons, or individuals with specific allergies are foreseen—materially

The ideal outcome of compliance with product design and development requirements is the creation of systems whereby new and modified products are subjected to systematic hazard analysis prior to introduction into the factory environment or release to consumers. This analysis should identify not only the hazards themselves but also the practical feasibility of controlling those hazards within the operating context of the manufacturing business. Additionally, the procedures should ensure that formal approval by appropriately qualified personnel occurs before products are introduced, thereby creating documented evidence of reasoned decision-making and reducing the likelihood of products being manufactured that later prove unsafe or non-compliant.

A well-implemented product design and development procedure contributes substantially to the credibility of a food manufacturer’s overall safety management system. It demonstrates to customers, regulators, and third-party auditors that the business operates a proactive, prevention-focused approach rather than a reactive one. For manufacturers operating under stringent retail or food-service customer requirements, documented evidence of formal new product approval processes—together with supporting hazard analyses and validation records—frequently constitutes essential due-diligence documentation. Furthermore, for manufacturers experiencing changes in market circumstances, ingredient availability, or formulation pressures (such as demands for reduced salt, sugar, or artificial preservatives), a systematic procedure for evaluating the implications of such changes for product safety and stability provides a disciplined framework for managing reformulation decisions.

Overview of Compliance

Food manufacturers pursuing compliance with product design and development requirements should operate documented management systems comprising several interconnected elements:

Documented Procedures: A formal, written procedure (or set of procedures) should define the step-by-step process by which new products or material changes to existing products are evaluated, approved, and introduced into production. This procedure should specify who is responsible for each stage, what decisions must be made, and what documentation must be retained.

Cross-Functional Teams: The procedure should mandate the involvement of personnel from relevant departments—including research and development, quality assurance, production operations, engineering, microbiology, and potentially procurement and customer-facing functions—to ensure that diverse perspectives inform product development decisions.

Hazard Analysis Integration: The procedure should require that hazard analysis (aligned with HACCP principles) forms part of the new product evaluation process, ensuring that significant hazards are identified and that practical controls are specified before production commences.

Process Flow Documentation: Systems should be established to capture, validate, and maintain process flow diagrams depicting each product’s journey from raw material receipt through to finished product dispatch, including all process steps, equipment, and potential hazard control measures.

Shelf-Life and Stability Records: Procedures should establish the conduct of shelf-life trials using documented protocols that reflect real commercial storage and handling conditions, with results retained as evidence supporting the shelf-life claims made on product labels.

Change Control: The documented system should include a formal change management mechanism whereby modifications to products, formulations, or processes are formally notified to, evaluated by, and approved by designated personnel before implementation.

These documented systems can be aligned with operational practices through clear communication to all relevant staff, training on the procedures, and regular review of procedure compliance during internal audits and management reviews. The flexibility inherent in well-designed procedures allows manufacturers of differing sizes and complexities to adapt the framework to their specific circumstances, from small artisanal producers to large multinational enterprises.

Documented Systems

Product Design and Development Procedure

A comprehensive product design and development procedure should detail the mechanism by which new products or material changes to existing products are formally introduced. The procedure should include several specific components:

Scope and Applicability: The procedure should clearly define what constitutes a “new product” or a “material change” triggering the full development process, as opposed to minor, non-safety-affecting variations. Material changes typically include alterations to product formulation (ingredient type, proportion, or origin), process parameters affecting safety or legality, packaging system, target consumer group, storage conditions, or any manufacturing steps outsourced to third parties.

New Product Approval Workflow: The procedure should establish a documented workflow specifying the sequence of actions required from product conception through to commercial launch. At a minimum, this workflow should include stages for: formulation development and raw material sourcing; preliminary hazard assessment; process trial activities; shelf-life and stability studies; final hazard analysis and HACCP review; regulatory compliance check; approval decision; and implementation planning.

Restrictions on Scope: The procedure should explicitly identify any restrictions to the scope of new product development that reflect site-specific limitations or customer requirements. For example, a manufacturer might restrict new product development to exclude ingredients posing unacceptable allergen risks, products requiring equipment not present on site, or products whose processing hazards exceed the demonstrated capability of existing control measures. Such restrictions should be documented and understood by staff involved in product development activities.

Hazard Identification Component: Integral to the procedure should be a requirement for the identification and preliminary assessment of hazards that would be unacceptable to the site or its customers. This might include hazards associated with allergen introduction (such as the introduction of tree nuts, shellfish, or sesame into a facility previously free of such allergens), the introduction of pathogenic microbiological hazards for which no existing controls are in place (such as introduction of animal products into a previously vegetarian facility), chemical or physical contamination risks, or the introduction of ingredients subject to fraud or adulteration.

Raw Material and Ingredient Specifications

For each raw material and ingredient entering into a new product formulation, detailed specifications should be developed that define the acceptable chemical, microbiological, physical, and allergen properties of that material. Specifications should reflect the risk assessment conducted for each material and should form the basis of supplier approval and goods receipt procedures. Specifications should be maintained in accessible formats and reviewed at defined intervals (typically annually or whenever a material source changes) to ensure continued alignment with current product safety requirements.

Process Specifications and Work Instructions

Once a product formulation is developed, detailed process specifications should be documented that translate the formulation into practical manufacturing steps. These specifications should define, with specificity:

• Sequence and duration of mixing or processing steps
• Equipment required and specific settings (temperature, pressure, speed, time)
• Critical process parameters affecting safety, legality, or intended quality characteristics
• Cooling, storage, and holding times and temperatures
• Packaging and labelling requirements
• Allergen control measures specific to the product
• Any critical control points identified in the product’s HACCP assessment

Process specifications should be written in sufficient detail to enable production staff to manufacture the product consistently. They should reflect the conditions that have been validated during product trials and should not differ materially from the conditions under which shelf-life and stability have been tested.

Shelf-Life and Stability Study Records

Detailed records should be maintained documenting the shelf-life and stability testing undertaken for each product. These records should include:

• The protocols used for shelf-life studies, specifying the storage conditions evaluated (temperature, humidity, light exposure, and any “temperature abuse” scenarios mimicking real commercial cold-chain conditions)
• The parameters tested at each interval (microbiological, chemical, physical, and sensory properties)
• The frequency and duration of testing relative to the claimed shelf-life
• Test results, including the date results were obtained, the specific measurements, and any trends observed
• Evidence of microbiological testing for both spoilage organisms and, where relevant, pathogenic organisms of concern
• For chilled products, testing under both recommended storage conditions and mild temperature-abuse conditions
• For ambient-shelf-life products, consideration of accelerated shelf-life testing where real-time studies would be impractical
• Evidence supporting any claims regarding shelf-life extension by consumers (for example, freezing) if such extension is anticipated

The records should demonstrate that the claimed shelf-life accurately reflects the product’s stability under the storage and handling conditions anticipated in commercial practice. Where shelf-life claims are based, in part, on accelerated shelf-life testing or mathematical models of microbial growth, documented evidence should support the validity of the acceleration or modelling approach used.

Product Specification Documentation

Comprehensive product specifications should be documented for each new product, capturing all relevant information affecting customer requirements, safety, legality, and quality. Product specifications should include:

• Detailed product description and intended use
• Target consumer groups and, critically, any vulnerable populations (such as infants or individuals prone to specific allergies) anticipated to consume the product
• Ingredient list, including identification of all allergens present
• Nutritional composition (where applicable and required)
• Physical characteristics (such as colour, texture, consistency, flavour)
• Microbiological and chemical limits and specifications
• Packaging type and specifications
• Storage requirements and conditions
• Claimed shelf-life and “best before” or “use by” dating
• Labelling information, particularly allergen declarations and any legally required claims
• Supplier information for critical raw materials

Product specifications should be formally agreed with the customer (where the product is manufactured to customer specification) or formally approved by authorised personnel within the manufacturer’s business before production commences. Specifications should be reviewed periodically (typically no less than every three years) and whenever material changes are made to the product, its sourcing, or regulatory requirements affecting it.

Validation Records for Trials

Documentation should be retained demonstrating that products have been manufactured using representative equipment and processes, and that the product and manufacturing process are capable of producing safe product of the required quality. Validation records should include:

Equipment Trials: Records demonstrating that trial batches have been produced using production-scale (or demonstrably representative) equipment should be maintained. Where new equipment is used for production, records should show that the equipment has been operated under the conditions specified in the process specification and that products produced meet the product specification.

Process Validation Records: Documentation should show that trial batches have been produced in a manner representative of the process conditions anticipated in full-scale production, and that the product characteristics (both safety-critical and quality-related) achieved during trials are consistent with expectations.

Shelf-Life Trial Records: As described above, documented evidence of shelf-life trials conducted using representative trial batches should be retained, demonstrating that products remain safe and of acceptable quality throughout the claimed shelf-life.

Temperature Distribution and Homogeneity Studies: For processes in which temperature distribution is critical to safety or legality (such as retort sterilization, cooking, cooling, or temperature-dependent storage), records should document that the manufacturing process achieves uniform conditions throughout the product batch, such that all product receives at least the minimum required heat treatment or cooling.

Practical Application

New Product Development Process Flow

In practical terms, new product development should progress through a series of sequential phases, each building upon the previous one:

Phase 1: Concept and Preliminary Assessment

When a new product concept is identified—whether through internal innovation, customer request, or market opportunity—the product development process should commence with preliminary assessment by appropriate personnel (typically a cross-functional team including R&D, quality, and production representatives). During this phase:

• The product concept should be described in outline, including the intended consumer base, key characteristics, and anticipated manufacturing approach
• A preliminary assessment should be undertaken of any apparent restrictions on feasibility—such as allergen concerns, process equipment limitations, or hazards that appear uncontrollable within the site’s current operating context
• If the product appears feasible, formal initiation of the development process should occur, with responsibilities assigned and timelines established

Phase 2: Formulation Development and Raw Material Selection

Following preliminary approval, the product formulation should be developed and raw materials selected. This phase should include:

• Identification and sourcing of candidate raw materials and ingredients aligned with the product concept
• A documented risk assessment of each raw material, considering potential allergen contamination or content, microbiological risks, chemical hazards, physical contamination risks, and any fraud or adulteration concerns specific to that material
• Preliminary development of the product formulation using appropriate raw materials identified as acceptable through the risk assessment
• If the product involves significant process innovations or ingredients not previously used by the manufacturer, preliminary hazard analysis to identify potential concerns requiring further investigation

Where new ingredient sources are being evaluated, consideration should be given to whether pilot quantities can be obtained that enable preliminary stability or sensory testing before committing to full-scale trials. Equally, for products involving new processing approaches, small-scale trials (conducted in a controlled manner, such as in a pilot or test kitchen area) may yield valuable learning before investment in full production trials.

Phase 3: Preliminary Hazard Assessment and HACCP Scoping

Before commencing production trials, a preliminary but documented hazard assessment should be undertaken. This assessment should:

• Identify all potentially significant hazards associated with the product and its formulation, considering microbiological, chemical, physical, and allergen hazards
• Consider whether hazards arise from raw material contamination, introduction during processing, survival of existing hazards through processing, or the potential for environmental contamination
• Identify any hazards that are unacceptable (because no practical control exists or the hazard cannot be reconciled with site requirements) and escalate these concerns for decision by appropriate management personnel
• Scope the critical control points and prerequisite programmes likely to be required for the product’s HACCP plan
• Identify any particular process controls, environmental conditions, or resource requirements necessary to ensure the product can be produced safely

This preliminary assessment should be documented (in any form appropriate to the business, from formal HACCP worksheets to brief technical notes) and should form the basis of decisions regarding trial batch planning.

Phase 4: Trial Batch Production

Following preliminary assessment, trial batches of the product should be produced using representative production equipment and processes. The conduct of trial batches should:

• Employ production-scale equipment or equipment demonstrably representative of production conditions (such as pilot equipment employing similar heat transfer mechanisms or mixing principles)
• Follow the process specification and conditions proposed for full commercial production
• Document the actual process parameters achieved during the trial (temperatures, times, pressures, and other critical parameters)
• Include collection of samples for stability and shelf-life testing
• Capture feedback from production staff regarding any process difficulties, equipment interactions, or practical concerns that emerge during trial manufacture
• Generate data on product yield, quality characteristics, and any process variability requiring attention

Trial batches should be of sufficient scale to generate confidence that the process will behave similarly when scaled to full commercial production. Additionally, trial batches should be manufactured in a manner that reflects the allergen control and hygiene conditions anticipated during full commercial production (for example, if a product will be manufactured in a dedicated time-segregated area, the trial should reflect such segregation rather than manufacturing in a general-purpose area).

Phase 5: Shelf-Life and Stability Testing

Samples from trial batches should be subjected to shelf-life and stability testing according to a documented protocol reflecting the storage conditions anticipated in commercial practice. Testing should:

• Be undertaken under the storage conditions specified for the product (such as refrigerated, ambient, or frozen storage)
• Include realistic representations of commercial temperature variation and abuse (such as mild temperature excursions anticipated during transport or retail display)
• Progress for a period exceeding the claimed shelf-life
• Measure critical parameters at predetermined intervals, including microbiological characteristics (for example, aerobic plate count, pathogenic organisms, spoilage organisms specific to the product category), chemical stability (such as pH, water activity, or preservation system effectiveness), physical characteristics (such as texture, appearance, or package integrity), and sensory properties (such as flavour, aroma, or colour)
• Include challenge testing where appropriate—for instance, inoculating trial product with surrogate or pathogenic organisms to verify that growth does not occur under the claimed storage conditions
• Document all results and any trends observed (such as gradual changes in characteristics that might indicate approaching spoilage or product failure)

For products with extended shelf-lives (for example, 12 months or longer), accelerated shelf-life testing approaches may be employed to compress testing timescales, provided that the acceleration methodology is justified by reference to published literature, prior data on equivalent products, or mathematical models of product degradation. However, unless published precedent strongly supports the validity of acceleration approaches, a minimum period of real-time shelf-life testing should generally be conducted to validate the claimed shelf-life.

Phase 6: Process and HACCP Finalisation

Following trial batch completion and initial shelf-life data review, the product’s process specification and HACCP plan should be finalised. This finalisation should:

• Incorporate learnings from trial batches regarding process parameters, equipment interactions, and any practical constraints identified
• Document the complete HACCP plan in accordance with Codex Alimentarius principles, including identification of all potential hazards, evaluation of their significance, specification of critical control points, establishment of critical limits, definition of monitoring procedures, specification of corrective actions, and specification of verification procedures
• Ensure that hazard controls are realistic and achievable within the manufacturing context of the business
• Identify and document any prerequisite programmes upon which hazard control depends (such as allergen segregation procedures, preventive maintenance of temperature monitoring equipment, or hygienic operation of production areas)
• Ensure alignment between the process specification and the HACCP plan—that is, the process conditions specified should faithfully represent the conditions for which the hazard control strategy has been developed and validated

Phase 7: Regulatory and Quality Review

Before approval for commercial production, the product should be subjected to a formal regulatory and quality review. This review should:

• Verify that the product, as formulated and labelled, complies with all applicable food safety legislation in the anticipated country or countries of sale
• Confirm that all required allergen information is accurately captured on product labels
• Verify that compositional and nutritional claims (if any) are accurate and supported by data
• Confirm that product shelf-life dating is appropriate and supported by shelf-life study data
• Identify any labelling, composition, or process requirements specific to customer specifications
• Ensure that ingredient sourcing and supplier approvals are in order

Phase 8: Formal Approval and Implementation

Following completion of the above phases, formal approval for commercial production should be granted by appropriately qualified personnel (typically quality assurance management or a cross-functional approval committee). The approval should be documented, typically by means of a formal product approval record or deviation from specification form, capturing:

• Confirmation that all required reviews and trials have been completed satisfactorily
• Identification of any residual concerns or areas requiring ongoing monitoring
• Specification of the product launch date or commencement of commercial production
• Implementation arrangements, including notification to all relevant staff, training on the new product, and any facility modifications or equipment qualifications required

Following formal approval, the product should be transitioned into the regular production and quality management system, including:

• Communication to production staff of the new product, its specifications, and any special handling or control requirements
• Training of relevant personnel on the product’s process specification and any specific hazard controls
• Incorporation of the product into the internal audit programme
• Inclusion of the product in the regular shelf-life monitoring programme (if shelf-life monitoring is undertaken for the product category)

Material Changes to Existing Products

Existing products may require modification for various reasons: changes in ingredient availability or cost, reformulation to reduce salt or sugar, modification of packaging systems, or changes to process equipment or conditions. Modifications to existing products should be approached using a systematically identical process to new product development, with rigour proportionate to the significance of the change:

• Minor changes (such as a change in packaging material that does not affect product storage properties, or a change to an insignificant ingredient not contributing to safety or stability) may be subject to a simplified approval process, provided that the change has been assessed and documented as posing no risk to product safety, legality, or quality
• Material changes (such as reduction of salt or sugar affecting product stability, change in process temperature or time affecting microbiological safety, or introduction of a new raw material source) should trigger a full re-evaluation using the new product development process

The re-evaluation should specifically consider:

• Whether the change affects any identified hazards or critical control points in the product’s existing HACCP plan
• Whether the change alters the product’s microbiological or chemical stability, necessitating shelf-life re-testing
• Whether the change introduces new allergen risks or affects existing allergen segregation procedures
• Whether any process control equipment or monitoring capability requires modification or re-qualification

Changes should be formally documented, including the reason for the change, an assessment of implications for safety and quality, any testing or trials undertaken, and formal approval before implementation.

Production and Operational Considerations

Once approved, the practical day-to-day operation of a new product within the manufacturing facility should reflect the conditions for which the product has been designed and validated:

Procurement and Raw Material Control: Production staff (particularly those in goods receipt) should be made aware of any specific sourcing requirements or quality standards applicable to the product’s raw materials. Changes to raw material sources should not be permitted without reference to and approval by appropriate quality personnel.

Process Adherence: Production staff should be trained on the product’s specific process requirements and should follow the documented process specification consistently. Any deviation from specified process parameters should be addressed in accordance with the site’s corrective action procedures, with consideration given to whether products manufactured outside specification are safe for release or require quarantine pending investigation.

Documentation and Record-Keeping: Production records for the product should capture all relevant process parameters, equipment conditions, and any deviations from specification. These records provide essential evidence of compliance with the product’s HACCP plan and support the site’s due-diligence documentation.

Staff Awareness and Responsibility: For products introducing new allergens or requiring special handling (such as products in specific production zones or requiring segregated equipment), all relevant staff should be made explicitly aware of these requirements. Staff should understand the purpose of allergen segregation or special handling and should know how to report concerns regarding potential cross-contamination or non-compliance.

Pitfalls to Avoid

Food manufacturers developing and introducing new products frequently encounter several recurrent challenges and shortfalls. Understanding these pitfalls and the approaches to overcome them can substantially improve the effectiveness of product development processes:

Insufficient Allergen Risk Assessment

One of the most frequent sources of difficulty is incomplete assessment of allergen risks during product development. This often manifests in several ways:

• Failure to capture hidden allergen sources: Manufacturers may focus on obvious allergen ingredients (such as peanuts or milk) but overlook allergens present in processing aids, non-declared ingredients, or secondary raw materials (such as emulsifiers or additives sourced from allergenic crops)
• Inadequate assessment of cross-contamination risks: The introduction of a new allergen into a facility may pose risks to other products manufactured in adjacent areas, using shared equipment, or handled by the same personnel. Thorough assessment of existing procedures and potential for cross-contact is essential
• Incomplete supplier knowledge: Where raw materials are sourced from brokers or agents rather than directly from manufacturers, complete knowledge of ingredient sources and allergen status may not be readily available, creating uncertainty regarding allergen content

To mitigate allergen assessment shortfalls, manufacturers should:

• Implement systematic allergen questionnaires for all new suppliers, explicitly requesting detail on not merely the primary allergen content of materials but also potential cross-contamination within supplier facilities
• Conduct cross-functional review of allergen implications when new products are developed, engaging staff from quality, procurement, and production to ensure that facility-wide implications are considered
• Document evidence of allergen assessment and, where the product introduces a new allergen to the facility, document the procedures implemented to prevent cross-contamination
• Maintain awareness of evolving allergen labelling requirements in different markets, as these may necessitate product reformulation or enhanced allergen control procedures

Inadequate Scale-Up Process Validation

A recurrent pitfall involves developing and validating new products at small scale (such as in development kitchens or pilot equipment) and then transitioning to full-scale production without adequate process validation at intermediate scales or under full production conditions. This frequently results in:

• Unexpected process difficulties: Heat transfer characteristics, mixing efficiency, or equipment dwell times may differ substantially at full scale compared to pilot scale, resulting in products that differ materially from those validated in trials
• Loss of process control: Temperature or pressure profiles achieved during pilot trials may not be reproducible at full scale, compromising the validity of microbiological or safety assumptions built into the HACCP plan
• Shelf-life surprises: Products manufactured at full scale may exhibit different stability characteristics than trial batches, potentially resulting in products approaching end-of-shelf-life before reaching consumers

To address scale-up challenges:

• Conduct trials at progressive scales (bench-scale to pilot-scale to semi-works scale), with intermediate-scale trials validating that process assumptions remain valid as scale increases
• For processes involving heat treatment critical to safety (such as cooking, retort sterilisation, or pasteurisation), conduct process validation at full scale under the exact conditions proposed for commercial production, with measurement of temperature distributions within representative product batches to verify uniform treatment
• Engage production and engineering staff early in product development to ensure that proposed processes are practically achievable within the facility’s operating context and that equipment limitations are understood
• Where process parameters differ between pilot trials and full-scale production (for instance, where full-scale equipment settings or dwell times differ from pilot conditions), conduct re-validation under the full-scale conditions to verify that the product remains safe and of acceptable quality

Inadequate Shelf-Life Data

Another frequent shortcoming involves claiming shelf-lives on product labels that are not adequately supported by shelf-life study data. This manifests in several ways:

• Arbitrary shelf-life claims: Some manufacturers assign shelf-lives based on industry practice or competitor products without conducting specific testing of their own product
• Insufficient testing duration: Shelf-life studies may be terminated before the full claimed shelf-life period has elapsed, creating uncertainty regarding product stability in the later stages of the claimed shelf-life
• Testing under non-representative conditions: Shelf-life trials may be conducted under ideal storage conditions (such as constant 20°C temperature) without reflecting the temperature abuse and variability likely to occur in commercial supply chains
• Microbiological assumptions without testing: For chilled products, manufacturers may assume that pathogenic organisms will not grow under refrigerated conditions without conducting challenge testing to validate this assumption

To ensure adequacy of shelf-life data:

• Conduct shelf-life trials specifically for each product or, where a genuine family of products with identical formulations and process conditions exists, document evidence that the shelf-life claim is applicable to the entire family
• Conduct testing for at least the full duration of the claimed shelf-life, continuing testing beyond the claimed date if trends suggest product quality may be declining
• Include realistic temperature-abuse scenarios in testing protocols, reflecting the conditions anticipated in the commercial cold chain or retail environment
• For chilled products, conduct challenge testing with relevant pathogenic organisms under the worst-reasonably-anticipated storage conditions to verify that the food is safe under the claimed shelf-life
• Document not merely the final results but also the trend in results across the testing period, as this provides evidence regarding the appropriateness of the shelf-life claim and can identify products approaching spoilage earlier than anticipated

Inadequate Approval Authority and Cross-Functional Engagement

Some manufacturers establish product development procedures but fail to ensure adequate cross-functional engagement or appropriate approval authority. This results in:

• Siloed development decisions: R&D personnel may develop products without adequate input from quality, production, or microbiology perspectives, resulting in products that are later found to pose uncontrollable hazards or present manufacturing difficulties
• Lack of accountability: Where approval authority is unclear or distributed across too many personnel, responsibility for product approval may become diffuse, with no individual taking clear ownership of the approval decision
• Failure to escalate concerns: Where procedures do not establish a clear mechanism for raising concerns or requesting exception to procedure, staff may introduce products into production despite known concerns

To strengthen approval processes:

• Establish clear assignment of responsibility for each stage of product development, with identified individuals accountable for evaluation and approval at each stage
• Require documented cross-functional review at key stages (at minimum, before commencing production trials and before formal approval for commercial production)
• Establish a clear mechanism for escalating concerns or requesting exceptions to standard procedure, ensuring that exceptional requests are reviewed by senior management with appropriate documentation of decisions and rationales
• Conduct regular review of the product development procedure and the approval decisions made under it to identify patterns of difficulty or common concerns that might indicate procedure modifications are warranted

Insufficient Documentation and Record Retention

Particularly in smaller manufacturing businesses, product development decisions may occur informally, with limited documentation. This creates several difficulties:

• Loss of institutional knowledge: When personnel responsible for product development depart, knowledge of why specific decisions were made, what concerns were considered, or what trials were conducted may be lost
• Inability to respond to customer inquiries or regulatory investigations: Where detailed development and trial data are not retained, manufacturers cannot readily respond to queries regarding product safety or compliance
• Inability to implement similar products: Where development data are not documented, subsequent development of similar or related products must commence without benefit of prior learning

To strengthen documentation practices:

• Establish a standardised template or record form for product approval decisions, capturing at minimum the product name, approval date, approving personnel, a summary of the hazard assessment, a summary of trial results, and any conditions or concerns associated with the approval
• Retain shelf-life and trial batch records for at least the shelf-life of the product plus 12 months, as these provide essential evidence of the product’s safety and stability
• For products subsequently withdrawn or extensively reformulated, retain records of the previous formulation and any issues that prompted change, as this supports decisions regarding subsequent product development
• Establish systems for document retention (whether paper-based or electronic) that protect records against loss and ensure ready retrievability when needed

Change Management and Ongoing Product Evolution

A subtle but important pitfall involves the failure to recognise that formal change management procedures should apply to existing products, not merely new product development. This results in:

• Undocumented reformulations: Products may be gradually modified (such as through incremental changes to ingredient sources or process settings) without formal evaluation of whether changes collectively constitute a material modification requiring re-evaluation
• Loss of control following customer changes: Where customers specify changes to product formulations or processes, formal evaluation of the implications may be overlooked, resulting in products manufactured under conditions materially different from those validated

To address change management challenges:

• Establish explicit procedure requiring that any change to product formulation, process specification, or raw material sourcing be formally evaluated and approved before implementation
• Define what constitutes a “material change” requiring full re-evaluation (such as any change affecting product safety, stability, or allergen status) as opposed to a “minor change” subject to simplified approval
• Ensure that all product changes—whether requested by customers, driven by supplier availability, or initiated internally—are subject to the same formal evaluation and approval process
• Conduct periodic (at least annual) management review of all product reformulations and modifications undertaken, with assessment of whether any cumulative changes have collectively altered the product’s safety or control profile

In Summary

Effective product design and development constitutes one of the most significant preventive systems a food manufacturer can implement. By embedding food safety thinking at the earliest stages of product conception and subjecting new and modified products to systematic hazard assessment, validation, and approval before commercial production, food manufacturers substantially reduce the risk of manufacturing unsafe or non-compliant products and mitigate the possibility of costly product recalls or regulatory enforcement action.

The practical implementation of product design and development procedures requires documented processes capturing the stages through which products progress from conception to commercial manufacture. These procedures should establish clear assignment of responsibility, require cross-functional engagement, incorporate formal hazard assessment and HACCP development, mandate shelf-life and stability validation, and establish unambiguous approval authority before products are released to production.

The core requirements addressed by such procedures are, in essence, straightforward: manufacturers should know the products they produce, should understand the hazards associated with those products, should validate that practical controls exist to manage those hazards, and should maintain documented evidence demonstrating that such knowledge and validation exists. The procedure should extend beyond new product development to encompass material modifications to existing products, recognising that even established products may require re-evaluation if their formulation, process, or sourcing materially changes.

For manufacturers contending with contemporary market pressures—such as demands for reformulated products with reduced salt, sugar, or artificial preservatives—systematic product development and change management procedures provide the disciplined framework within which such reformulations can be undertaken without compromising food safety. Similarly, for manufacturers operating in multi-customer environments where different customers specify different formulations or requirements for the same basic product category, documented procedures ensure consistency and prevent the inadvertent introduction of non-compliant products or products not appropriately evaluated for feasibility within the manufacturing context.

The significance of comprehensive product design and development procedures extends beyond mere compliance with standards. Such procedures demonstrate to customers, regulators, and business partners that a manufacturer operates a genuinely prevention-focused food safety culture in which safety is embedded in decision-making at the earliest stages rather than retrofit at later ones. The documented evidence of systematic hazard assessment, validation, and approval provides the foundation for credible due-diligence documentation and supports the manufacturer’s position that products are designed, manufactured, and released with full understanding of and commitment to food safety.